(Q42277126)

English

Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab).

scientific article published on 29 January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Burkitt lymphoma

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Josep-Maria Ribera

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Olga García

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Carlos Grande

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Jordi Esteve

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Juan Bergua

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

José González-Campos

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Ferran Vall-Llovera

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Jesús-Maria Hernández-Rivas

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Daniel García

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Salut Brunet

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Natalia Alonso

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Pere Barba

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Pilar Miralles

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Andreu Llorente

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Pau Montesinos

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Maria-José Moreno

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Jose-Ángel Hernández-Rivas

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Teresa Bernal

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

0 references

publication date

29 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

119

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1660-1668

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

Burkitt lymphoma in adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

How I treat HIV-associated lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

Controversies in the treatment of Burkitt lymphoma in AIDS

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

Population based study of prognostic factors and treatment in adult Burkitt lymphoma: a Swedish Lymphoma Registry study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

21 January 2018

RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of rituximab to high-dose methotrexate-based chemotherapy improves survival of adults with Burkitt lymphoma/leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27918

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.27918

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361927%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42277126&oldid=1569025034"